MS Therapy Centre

Information About our News Feeds

The News Feeds displayed on this page are collected and updated from reputable 3rd Party Resources and Publications both National and International. The Wolverhampton MS Therapy Centre takes care in only including those resources it feels may benefit its Clients and Carers.

Occasionally some News Feeds are not made available for us to display and an error message may appear above, this simply means that a particular news article about MS is not available and does not affect the integrity of this site.

The Wolverhampton MS Therapy Centre cannot accept any legal responsibility for the accuracy or relevance of any information or any consequences that may arise from any actions taken from any information made available from the supplied News Feeds.

All information that is collected and displayed is offered in good faith.

Latest Multiple Sclerosis News

‘Crip Camp’: Disability Looking Me Right in the Eye
Multiple Sclerosis News Today Aug 7, 2020 | 08:45 am
In early July, I wrote a column about Disability Pride Month. It’s not for me, I said. I questioned the word “pride” and asked whether we need a special month to advocate for a more inclusive world. Several people commented[…]
Read more...
New Patent Filing for QuadraMune Relates to Potential in Aiding Memory
Multiple Sclerosis News Today Aug 7, 2020 | 07:15 am
Therapeutics Solutions International has announced filing a new patent covering the memory protective effects of its natural nutritional supplement QuadraMune, as seen in an animal model of memory loss caused by inflammation. QuadraMune is a nutritional supplement, available in capsule form, made of[…]
Read more...
8 Surprising MS Symptoms
Society for Multiple Sclerosis Patients in Pakistan Jul 22, 2020 | 13:43 pm
Living with Multiple Sclerosis is not easy. MS patients may experience a very good day today but unexpectedly, face symptoms the next day. Some Multiple Sclerosis symptoms are common in many patients, such as fatigue, pain, tingling and numbness, sexual[…]
Read more...
Siponimod Reduces Risk of Disability Progression Regardless of Prior Relapses in MS
Multiple sclerosis on Neurology Times Jun 4, 2020 | 03:21 am
The Novartis agent showed benefit in patients who had multiple sclerosis both with and without relapses.
Read more...
Ofatumumab Increases NEDA-3 Likelihood in MS Compared With Teriflunomide
Multiple sclerosis on Neurology Times Jun 4, 2020 | 03:11 am
Novartis’s anti-CD20 monoclonal antibody has been shown to increase the odds of patients with multiple sclerosis achieving no evidence of disease activity status by more than 3-fold in the first year and more than 8-fold in the second year.
Read more...
Humanitarian Service Awards 24 Oct 2019
Society for Multiple Sclerosis Patients in Pakistan Oct 9, 2019 | 13:27 pm
The Society for Multiple Sclerosis Patients in Pakistan is proud to announce that we have been invited to attend the 24th Humanitarian Service Awards Ceremony to be held at Islamabad Hotel, Islamabad, on Thursday 24 October 2019. Our Society has[…]
Read more...